<DOC>
	<DOCNO>NCT02188017</DOCNO>
	<brief_summary>An randomized trial two maintenance dos Acthar Gel patient chronic pulmonary sarcoidosis . Patients observe 24 week treatment .</brief_summary>
	<brief_title>Acthar Gel Chronic Pulmonary Sarcoidosis ( ACPS )</brief_title>
	<detailed_description>This multi-center double-blind trial determine dose effect size . A total 20 chronic pulmonary sarcoidosis patient recruit eight clinical site across United States . After initial evaluation , include pulmonary function , CT PET scanning , patient randomize receive 80 Units Acthar gel daily 10days , follow either 40 80 unit Acthar gel twice week additional 22 week . At end total 24 week treatment , undergo repeat evaluation include pulmonary function , CT , PET scanning .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Sarcoidosis , Pulmonary</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Patient biopsy confirm sarcoidosis meeting American Thoracic Society criterion 23 Patient &gt; 5 mg prednisone pulmonary indication FVC &lt; 85 % predict Prednisone dose reduce prior 3 month Deterioration pulmonary disease past year Decrease FVC &gt; 5 % Age : 18 90 ( i.e. , candidate must 18th birthday , 91st birthday ) . adrenal insufficiency ( Addison 's disease ) Scleroderma fungal infection herpes infection eye osteoporosis stomach ulcer congestive heart failure high blood pressure recent surgery allergic pork protein Do receive smallpox vaccine `` live '' vaccine use corticotropin . Patients receive antiTumor Necrosis Factor antibody ( e.g . infliximab , adalimumab ) prior six month Uncontrolled diabetes , hypertension , contraindication increase dosage glucocorticoid Patients require therapy pulmonary hypertension Females childbearing potential know pregnant and/or lactate positive urine pregnancy test screening . Current participation another research drug treatment protocol ( patient start another experimental agent 90 day ) Any condition investigator feel would pose significant hazard patient Acthar Gel therapy initiate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>prednisone , methotrexate , sarcoidosis , azathioprine</keyword>
</DOC>